The World Stem Cell Summit & RegMed Capital Conference has invited five faculty members from the Nova Southeastern University (NSU) Cell Therapy Institute to present on their research related to advancing new approaches to cancer immunotherapy and regenerative medicine at the organization’s 12th annual meeting. 

The summit is being held at the Palm Beach County Convention Center in West Palm Beach on Dec. 6-9, 2016. It is the largest interdisciplinary stem cell meeting in the world, featuring more than 250 prominent scientists, business leaders, investors, philanthropists, regulators, policy-makers, economic development officers, patient advocates and experts in law and ethics, presenting the latest scientific discoveries, commercial and innovation opportunities, legal and regulatory solutions, and best practices. The event is expected to attract more than 1,200 attendees from 40 nations.
 
Presentations from the NSU Cell Therapy Institute will include:
● H. Thomas Temple, M.D., NSU senior vice president, translational research & economic development
Dr. Temple will discuss recent advances in bone and cartilage regeneration achieved by novel stem cell therapies and new approaches to treating sarcoma cancers.
● Richard Jove, Ph.D., director, NSU Cell Therapy Institute and co-chair, World Stem Cell Summit
Dr. Jove will provide an overview of the various collaborative research projects at NSU including cancer immunotherapy and stem cell programs targeting vision restoration and heart disease.
● Evren Alici, M.D., Ph.D., NSU visiting research professor from Karolinska Institutet
Dr. Alici will present novel approaches to cancer immunotherapy with a focus on targeted T-cells and natural-killer cells.
● Outi Hovatta, M.D, Ph.D., NSU visiting research professor from Karolinska Institutet
Dr. Hovatta will address recent progress in the development of stem cells for disease models and therapies.
● Karl-Henrik Grinnemo, M.D., Ph.D., NSU visiting research professor from Karolinska Institutet
Dr. Grinnemo will provide new insights into the differentiation of vital heart cells from stem cells for treatment of cardiovascular disease.